Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.300
-0.050 (-3.70%)
At close: May 29, 2026, 4:00 PM EDT
1.291
-0.009 (-0.71%)
After-hours: May 29, 2026, 7:48 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.23 million as of May 29, 2026. Its market cap has increased by 5.24% in one year.
Market Cap
5.23M
Enterprise Value
-1.72M
1-Year Change
5.24%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.23M, a decrease of -90.90%. That is a compound annual growth rate of -39.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.23M | -15.27% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 6.10M |
| SciSparc | 6.05M |
| XTL Biopharmaceuticals | 6.04M |
| Aptevo Therapeutics | 5.91M |
| CollPlant Biotechnologies | 5.82M |
| Bio Green Med Solution | 5.80M |
| Cardio Diagnostics Holdings | 5.34M |
| Matinas BioPharma Holdings | 5.09M |